Robotic surgery breakthrough: single-port approach tested for stomach cancer

NCT ID NCT07237126

Recruiting now Disease control Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 2 times

Summary

This early-stage study tests a new robotic surgery method that uses only one small incision to remove stomach cancer. The goal is to see if it is safe and works well. Twenty adults with stomach cancer will take part, and doctors will watch for complications during and up to 30 days after surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric adenocarcinoma gastric cancer gastric neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTRIC CANCER PATIENTS UNDERGOING GASTRECTOMY

Contacts and locations

Locations

Daping Hospital
NOT_YET_RECRUITING

Chongqing, Chongqing Municipality, 400042, China
Daping Hospital of Army Medical Universty
RECRUITING

Chongqing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.